Haematologica (Dec 2022)
Sirolimus as frontline therapy for <i>PTEN</i>-mutated histiocytic sarcoma
- Karan L. Chohan,
- Jithma P. Abeykoon,
- Jason R. Young,
- W. Oliver Tobin,
- Mathew J. Koster,
- Mithun V. Shah,
- Jay H. Ryu,
- Robert Vassallo,
- Karen L. Rech.,
- Aishwarya Ravindran,
- Gaurav Goyal,
- Ronald S. Go,
- N. Nora Bennani
Affiliations
- Karan L. Chohan
- Department of Medicine, Mayo Clinic, Rochester, MN
- Jithma P. Abeykoon
- Division of Hematology, Mayo Clinic, Rochester, MN
- Jason R. Young
- Department of Radiology, Mayo Clinic, Jacksonville, FL
- W. Oliver Tobin
- Department of Neurology, Mayo Clinic, Rochester, MN
- Mathew J. Koster
- Division of Rheumatology, Mayo Clinic, Rochester, MN
- Mithun V. Shah
- Division of Hematology, Mayo Clinic, Rochester, MN
- Jay H. Ryu
- Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN
- Robert Vassallo
- Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN
- Karen L. Rech.
- Division of Hematopathology, Mayo Clinic, Rochester, MN
- Aishwarya Ravindran
- Department of Laboratory Medicine-Hematopathology, Department of Pathology, University of Alabama, Birmingham, AL
- Gaurav Goyal
- Division of Hematology-Oncology, University of Alabama at Birmingham, Birmingham, AL
- Ronald S. Go
- Division of Hematology, Mayo Clinic, Rochester, MN
- N. Nora Bennani
- Division of Hematology, Mayo Clinic, Rochester, MN
- DOI
- https://doi.org/10.3324/haematol.2022.282207
- Journal volume & issue
-
Vol. 108,
no. 6
Abstract
No abstracts available.